Cholestyramine-fed AOM-treated mice had reduced levels of S1PR2 mRNA in the cortex compared to control diet-fed AOM-treated mice, supporting a role for total bile acids regulating S1PR2 expression in the brain (Figure 3I). The gene discussed is S1PR2; the disease is infectious otitis media.